Literature DB >> 24955780

Extractables and leachables considerations for prefilled syringes.

Dennis R Jenke1.   

Abstract

INTRODUCTION: Use of pre-filled syringes as both a packaging and delivery system for pharmaceutical drug products is accelerating. Pre-filled syringes must meet the quality and suitability for use requirements for both systems, including compatibility with the drug product. Relevant incompatibilities between pre-filled syringes and drug products include the safety of syringe-based leachables that accumulate in drug products and the ability of leachables to interact with the drug product's ingredients as such interactions can affect safety, efficacy, stability and physical viability. AREAS COVERED: Relevant suitability considerations for pre-filled syringes are discussed herein and specific examples of suitability for use issues for pre-filled syringes are cited, focusing on extractables associated with pre-filled syringes and leachables derived from such syringes. Aspects considered include the toxicological impact of leachables, their ability to alter the efficacy of drug products and to produce other undesirable outcomes such as aggregation and immunogenic responses. EXPERT OPINION: Materials used in pre-filled syringes and the conditions of use minimize the traditional safety risk associated with leachables. However, drug products that use pre-filled syringes are prone to non-traditional interactions such as disruption of protein conformation, leading to potential efficacy, safety and quality issues. In order to qualify pre-filled syringes for use, the traditional approach of measuring extractables and leachables and inferring their effect must be augmented by rigorous compatibility testing. Research into the fundamental relationship between leachables and drug substances will be necessary so the more time- and cost-efficient 'measure and infer' approach can be widely implemented.

Entities:  

Keywords:  aggregation; extractables; incompatibilities; leachables; pre-filled syringes; safety

Mesh:

Substances:

Year:  2014        PMID: 24955780     DOI: 10.1517/17425247.2014.928281

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  8 in total

1.  MAbDelivery: Administration routes for antibody therapy Third LabEx MAbImprove industrial workshop, July 2, 2015 Tours, France.

Authors:  Elsa Bodier-Montagutelli; Renaud Respaud; Hervé Watier; Audrey Guillon-Munos
Journal:  MAbs       Date:  2017-02-28       Impact factor: 5.857

2.  In Vivo Analysis of the Potency of Silicone Oil Microdroplets as Immunological Adjuvants in Protein Formulations.

Authors:  Carly Fleagle Chisholm; Bao Han Nguyen; Kaitlin R Soucie; Raul M Torres; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2015-07-17       Impact factor: 3.534

3.  Silicone Oil Microdroplets Can Induce Antibody Responses Against Recombinant Murine Growth Hormone in Mice.

Authors:  Carly Fleagle Chisholm; Abby E Baker; Kaitlin R Soucie; Raul M Torres; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2016-03-25       Impact factor: 3.534

4.  Does an interaction exist between ketamine hydrochloride and Becton Dickinson syringes?

Authors:  M Closset; J D Hecq; E Gonzalez; B Bihin; J Jamart; L Galanti
Journal:  Eur J Hosp Pharm       Date:  2016-10-12

Review 5.  Practical considerations in clinical strategy to support the development of injectable drug-device combination products for biologics.

Authors:  Zhaoyang Li; Rachael Easton
Journal:  MAbs       Date:  2017-11-07       Impact factor: 5.857

Review 6.  Biopolymers for Biomedical and Pharmaceutical Applications: Recent Advances and Overview of Alginate Electrospinning.

Authors:  Jolanta Wróblewska-Krepsztul; Tomasz Rydzkowski; Iwona Michalska-Pożoga; Vijay Kumar Thakur
Journal:  Nanomaterials (Basel)       Date:  2019-03-10       Impact factor: 5.076

7.  Oleamide, a Bioactive Compound, Unwittingly Introduced into the Human Body through Some Plastic Food/Beverages and Medicine Containers.

Authors:  Katerina Naumoska; Urška Jug; Valentina Metličar; Irena Vovk
Journal:  Foods       Date:  2020-05-01

Review 8.  Container Closure and Delivery Considerations for Intravitreal Drug Administration.

Authors:  Ashwin C Parenky; Saurabh Wadhwa; Hunter H Chen; Amardeep S Bhalla; Kenneth S Graham; Mohammed Shameem
Journal:  AAPS PharmSciTech       Date:  2021-03-11       Impact factor: 3.246

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.